FDA Approves Biosimilar to Treat Immune-Mediated Conditions (FREE)

By Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM The FDA has approved Inflectra (infliximab-dyyb) to treat several immune-mediated disorders.Inflectra is biosimilar to …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Primary Care | Remicade